Attenuation of skeletal muscle atrophy via protease inhibition.
about
Nutraceuticals and Their Potential to Treat Duchenne Muscular Dystrophy: Separating the Credible from the ConjectureDifferential localization of autolyzed calpains 1 and 2 in slow and fast skeletal muscles in the early phase of atrophyBowman-Birk inhibitor attenuates dystrophic pathology in mdx mice.The isolated muscle fibre as a model of disuse atrophy: characterization using PhAct, a method to quantify f-actin.The biochemical and functional food properties of the bowman-birk inhibitor.The Caenorhabditis elegans muscle specific serpin, SRP-3, neutralizes chymotrypsin-like serine peptidasesStaging of disuse atrophy of skeletal muscles on immunofluorescence microscopy.Chemotherapy-related cachexia is associated with mitochondrial depletion and the activation of ERK1/2 and p38 MAPKs.Mature IGF-I excels in promoting functional muscle recovery from disuse atrophy compared with pro-IGF-IA.The physiological response of protease inhibition in dystrophic muscle.Nutritional strategies to counteract muscle atrophy caused by disuse and to improve recovery.Involvement of AMPK in regulating slow-twitch muscle atrophy during hindlimb unloading in mice.Deficiency of inducible nitric oxide synthase attenuates immobilization-induced skeletal muscle atrophy in mice.Are Soy Products Effective in DMD?
P2860
Q28072269-78993D55-4215-44B1-BAF5-8726164B5A84Q28581873-01B6433F-3BD5-4A50-AD9B-5182BEF5BDDDQ34305281-9EDF9CB4-9CF9-448B-A6B5-F65B3DD73701Q35141295-6DBB21F6-A5C7-4469-922E-299849B55088Q37084669-E22737C3-F309-46B2-910E-963FDD255486Q37125044-E402E183-64B9-42A5-9BEF-692F75E565A1Q37174785-57BEAB35-9298-4D5F-AFDD-EF5CF86F2C8EQ37536603-3D1335E8-3275-48A8-A448-6F7CC11121CFQ37679375-041AE923-E8FD-4335-8941-DB4135A72B42Q38104503-4F4D2828-5D2D-42B8-AC75-4FB6DBF54158Q38127714-49650070-78EC-4E6D-A54C-4C9FF777FCDDQ52926464-98FB869F-1172-4724-85AC-0E02BCFDFB0FQ53379692-67A11B19-E091-4F82-920D-F67FA78EDE2AQ54980040-610B6262-46F7-4F4E-AEAA-9BCC06553E47
P2860
Attenuation of skeletal muscle atrophy via protease inhibition.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Attenuation of skeletal muscle atrophy via protease inhibition.
@en
Attenuation of skeletal muscle atrophy via protease inhibition.
@nl
type
label
Attenuation of skeletal muscle atrophy via protease inhibition.
@en
Attenuation of skeletal muscle atrophy via protease inhibition.
@nl
prefLabel
Attenuation of skeletal muscle atrophy via protease inhibition.
@en
Attenuation of skeletal muscle atrophy via protease inhibition.
@nl
P2093
P1476
Attenuation of skeletal muscle atrophy via protease inhibition.
@en
P2093
Ann R Kennedy
Carl A Morris
H Lee Sweeney
Linda D Morris
P304
P356
10.1152/JAPPLPHYSIOL.01419.2004
P407
P577
2005-06-23T00:00:00Z